Dr. Reddy's makes generic medicines, active pharmaceutical ingredients and consumer healthcare products. RDY reports earnings on Fri, Jan 22, 2027. In the past 30 days there were 1 dark pool print.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 29 | Citigroup | Upgrade | Buy |
Whale Options Flow
90DNo whale options trades in RDY in the last 90 days.
Dark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RDY is in one of them and how their past RDY trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered RDY in an article yet. Here's the latest on the wider market.
About DR Reddys Laboratories
Dr. Reddy's is a pharmaceutical company based in Hyderabad, India. It makes and sells generic medicines, both branded and unbranded, along with biosimilars and consumer healthcare products. It also manufactures active pharmaceutical ingredients, the core ingredients used in finished medicines, and offers contract research and manufacturing services to other drug companies. Its key markets include the United States, India, Russia, other former Soviet countries and Europe.
- Headquarters
- Hyderabad
- Founded
- 1984
- Website
- drreddys.com ↗